SIFCO Industries (NYSEAM) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
5 Oct, 2026Executive summary
Q3 FY2024 sales rose 33.9% to $29.3M from $21.9M; operating profit was $1.3M versus $0.03M, and net income was $0.07M versus a $0.6M loss.
Nine-month sales rose 23.2% to $76.9M; net loss narrowed to $4.9M from $5.6M. October 2024 debt maturity raises substantial doubt about continued operations absent refinancing or a strategic transaction.
Financial highlights
Q3 gross profit increased to $4.5M from $3.5M; gross margin was 15.5% versus 15.9%, with higher volume and lower idle expense offset by prior-year ERC benefits.
Nine-month gross profit rose to $8.0M from $6.5M; gross margin was 10.4% versus 10.3%. SG&A declined to $9.9M from $10.5M.
Q3 SG&A was $3.2M versus $3.4M, including a $0.6M cybersecurity-fee credit; prior-year results included a $1.5M ERC benefit in cost of goods sold.
Nine-month operating loss narrowed to $2.1M from $4.2M; net loss narrowed to $4.9M from $5.6M, partly on higher sales and gross margin, offset by labor and interest costs.
Outlook and guidance
Backlog was $139.2M at June 30, 2024, including $108.1M expected to be completed within 12 months; orders may be modified or canceled and may not predict sales.
Remaining FY2024 capital expenditures were expected at $1.0M–$1.5M, mainly for production and product capabilities and operating-cost reductions; commitments were $0.4M at June 30.
Maniago sale was expected to close in Q4 FY2024, subject to customary conditions, Italian Golden Power authorization and a material-adverse-condition clause.
Expected operating cash flows and domestic credit availability were cited as liquidity sources, but refinancing or another strategic transaction before debt maturity was not assured.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - H1 sales rose 10.9%, losses narrowed, and backlog reached $129.2M.NYSEAM
Q2 2025 - Higher military volumes and pricing drove a sharp return to profit, with financing and environmental risks persisting.NYSEAM
Q2 2026 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - ERC benefits and aerospace demand lifted Q3 profit; backlog stood at $130.4M.NYSEAM
Q3 2025 - Four directors, auditor ratification and a pause in FY2025 long-term awards headline the proxy.NYSEAM
Proxy filing - Military demand lifted nine-month results and backlog, while Q3 earnings absorbed a $3.2 million LIFO impact.NYSEAM
Q3 2026 - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026